Fermenta Biotech Key Ratios
NSE: FERMENTA | BSE: 506414
₹446.15
As on 20-Nov-2026IST
Market cap
₹1,312 Cr
Revenue (TTM)
₹513 Cr
P/E Ratio
25.5
P/B Ratio
3.1
Div. Yield
0.8 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.91 | 1.88 | -8.77 | 19.70 | 5.17 |
| EBIT | 15.87 | -29.83 | -48.95 | 76.18 | 4.45 |
| Net Profit | 0.31 | -48.25 | -58.64 | 93.56 | 7.02 |
| EPS | 0.16 | -47.58 | -53.46 | 40.38 | 9.34 |
| Book Value | -- | -- | 13.14 | 10.33 | 3.07 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 11.47 | 8.15 | 12.12 | 15.08 | 18.38 |
| Net Margin
| 7.26 | 2.13 | 9.37 | 12.82 | 15.87 |
| Return on equity
| 11.33 | 4.43 | 11.24 | 18.36 | 23.93 |
| Return on Capital
| 15.18 | 9.56 | -- | 21.99 | 21.97 |
| Return on Assets
| 6.65 | 2.88 | 7.36 | 11.13 | 12.85 |
| Debt to Equity (x)
| -- | -- | 0.01 | 0.27 | 0.30 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
21.99
|
21.97
|
1.58
|
-5.25
|
|
Peer Median
|
--
|
21.28
|
21.76
|
21.89
|
--
|
ROE
11.24
Lower than Peers by 3.68
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
11.24
|
18.36
|
23.93
|
-8.30
|
-16.11
|
|
Peer Median
|
14.92
|
18.29
|
17.93
|
16.42
|
--
|
ROA
7.36
Lower than Peers by 2.49
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
7.36
|
11.13
|
12.85
|
-4.01
|
-7.63
|
|
Peer Median
|
9.85
|
9.88
|
12.81
|
12.32
|
--
|
EBIT Margin
12.12
Lower than Peers by 5.55
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
12.12
|
15.08
|
18.38
|
0.94
|
-2.87
|
|
Peer Median
|
17.68
|
18.36
|
18.93
|
21.05
|
--
|
Net Margin
9.37
Lower than Peers by 4.40
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
9.37
|
12.82
|
15.87
|
-6.91
|
-14.82
|
|
Peer Median
|
13.77
|
13.31
|
14.94
|
15.51
|
--
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
17.50
|
21.43
|
0.21
|
-7.11
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-8.77
Lower than Peers by 21.42
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-8.77
|
11.92
|
39.87
|
-4.08
|
-12.19
|
|
Peer Median
|
12.65
|
16.05
|
10.90
|
13.44
|
--
|
EBIT Growth
-48.95
Lower than Peers by 72.34
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-48.95
|
-8.14
|
2,621.42
|
131.54
|
-127.41
|
|
Peer Median
|
23.39
|
20.72
|
15.01
|
23.50
|
--
|
Net Profit Growth
-58.64
Lower than Peers by 81.42
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-58.64
|
-8.05
|
418.23
|
54.81
|
-452.79
|
|
Peer Median
|
22.78
|
20.10
|
14.80
|
30.12
|
--
|
EPS Growth
-53.46
Lower than Peers by 74.87
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
-53.46
|
-5.01
|
429.95
|
54.88
|
-430.53
|
|
Peer Median
|
21.40
|
19.29
|
14.27
|
29.02
|
--
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
11.21
|
31.23
|
-8.59
|
-15.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.01
Higher than Peers by 0.01
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.01
|
0.27
|
0.30
|
0.48
|
0.72
|
|
Peer Median
|
0.00
|
0.05
|
0.06
|
0.03
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
0.23
|
0.22
|
0.23
|
0.32
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.69
Lower than Peers by 0.34
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1.69
|
1.86
|
1.50
|
1.35
|
1.19
|
|
Peer Median
|
2.03
|
1.90
|
1.90
|
2.23
|
--
|
Quick Ratio
1.02
Lower than Peers by 0.51
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1.02
|
1.13
|
1.00
|
0.90
|
0.63
|
|
Peer Median
|
1.54
|
1.40
|
1.46
|
1.59
|
--
|
Interest Coverage
6.99
Lower than Peers by 14.77
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
6.99
|
8.57
|
6.59
|
0.43
|
-1.40
|
|
Peer Median
|
21.76
|
19.02
|
24.96
|
45.29
|
--
|
Operating Efficiency
Debtors to sales
23.39
Higher than Peers by 2.14
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
23.39
|
21.24
|
20.28
|
20.80
|
11.90
|
|
Peer Median
|
21.25
|
20.44
|
21.77
|
20.10
|
--
|
Asset Turnover
0.76
Higher than Peers by 0.04
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.76
|
0.83
|
0.79
|
0.56
|
0.50
|
|
Peer Median
|
0.72
|
0.74
|
0.76
|
0.81
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
71.83
|
64.16
|
60.61
|
67.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
95.93
|
82.04
|
118.27
|
151.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
147.04
|
164.01
|
155.24
|
131.18
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
--
|
20.73
|
-17.81
|
23.64
|
87.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
25.55
Lower than Peers by 7.27
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
25.55
|
12.75
|
10.38
|
--
|
--
|
|
Peer Median
|
32.82
|
32.82
|
26.81
|
39.85
|
--
|
Price / Book Value
3.14
Lower than Peers by 1.15
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
3.14
|
2.27
|
2.20
|
1.58
|
1.02
|
|
Peer Median
|
4.29
|
4.39
|
4.65
|
6.11
|
--
|
Dividend Yield
0.84
Higher than Peers by 0.40
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
0.84
|
1.18
|
0.91
|
0.83
|
1.17
|
|
Peer Median
|
0.44
|
0.46
|
0.61
|
0.37
|
--
|
EV/EBITDA
13.75
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
13.75
|
7.96
|
6.83
|
12.84
|
17.44
|
|
Peer Median
|
--
|
24.76
|
27.02
|
34.57
|
--
|
Market Cap
1,312
Lower than Peers by 15,322
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
|---|---|---|---|---|---|
|
Fermenta Biotech
|
1,312
|
915
|
798
|
437
|
309
|
|
Peer Median
|
16,634
|
15,421
|
20,914
|
25,297
|
--
|